In HCC cell lines (i.e., Huh7 and HepG2), the increased expression of NACC-1 was demonstrated, and the downregulation of NACC-1 resulted in decreased cell proliferation and invasion, as well as increased susceptibility to doxorubicin-dependent chemosensitivity. The gene discussed is NACC1; the disease is hepatocellular carcinoma.